维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Mathot RA"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Alternative drug formulations of docetaxel:a review显示文摘	Engels FK Mathot RA Verweij J	2007	Anticancer Drugs2007，18，2：	1
2	A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 poly- morphism显示文摘	Hunfeld NG Touw DJ Mathot RA	2012	Aliment Pharmacol Ther2012，35，7：	1
3	Alternative drug formulations of docetaxel: a review 显示文摘	ENGELS FK MATHOT RA VERWEIJ J	2007	Anticancer Drugs2007，18，2：	1
4	Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic Meta-analysis of mycophenolic acid in renal transplant recipients显示文摘	van Hest RM Mathot RA Pescovitz MD	2006	J Am Soc Nephrol2006，17，3：	1
5	Impact of goal - oriented and model - based clinical pharmacokinetic dosing of aminoglyucosides on clinical outcome: a cost -effectiveness analysis 显示文摘	Van Lent Evens NA Mathot RA Gens WP	1999	Ther Drug Monit1999，21，1：	1
6	A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP 2C 19 polymorphism显示文摘	Hunfeld NG Touw D J Mathot RA	2012	Aliment Pharmacol Ther2012，35，7：	1
7	Alternative drug for- mulations of docetaxel: a review显示文摘	Engels FK Mathot RA Verweij J	2007	Anticancer Drugs2007，18，2：	1
8	Nicardipine in pre - eclamptic patients: placental transfer and disposition in breast milk 显示文摘	Barrels PA Hanff LM Mathot RA	2007	BJOG2007，114，2：	1
9	Alternative drug formulations of doeetaxel : a review 显示文摘	Engels FK Mathot RA Verweij J	2007	Anticancer Drugs2007，18，2：	1
10	A comparison of the acid-inhibitory effects of esomeprazole and rabe- prazole in relation to pharmacokinetics and CYP2C19 polymorphism 显示文摘	Hunfeld NG Touw DJ Mathot RA	2012	Aliment Pharmacol Ther2012，35，7：	1
11	Explaining variability in myeophenolie acid exposure to optimize my- cophenolate mofetil dosing--a population pharmacokinetie meta-analysis of mycophenolic acid in renal transplant re- cipients显示文摘	Vanhest RM Mathot RA Pescovitz MD	2006	J Am Soe Nephrol2006，17，3：	1
12	A comparison of the acid-inhibitory effects of esomeprazole and rabepra- zole in relation to pharmacokinetics and CYP2C19 poly- morphism显示文摘	Hunfeld NG Touw D J Mathot RA	2012	Aliment Pharmacol Ther2012，35，7：	1
13	Populatiort pharmacok inetics and pharmacodynamies of mitomycin during in traoperative hyperthermie intraperitoneal chemotherapy显示文摘	Ruth S Mathot RA Sparidans RW	2004	Clin Pharmaeoki- net2004，43，2：	1
14	A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism显示文摘	Hunfeld NG Touw DJ Mathot RA		0，，07：	1
15	Population pharmacokinetics of the novel anticancer agent KRN7000 显示文摘	Crul M Mathot RA Giaccone G	2002	Cancer Chemother Pharmacol2002，49，4：	1
16	Ahernative drug formulations of docetaxel : a review 显示文摘	Engels FK Mathot RA Verweij J	2007	Anticancer Drugs2007，18，2：	1
17	Alternative drug formulations of docetaxel : a review 显示文摘	Engels FK Mathot RA Verweij J	2007	Antieancer Drugs2007，18，2：	1
18	Impact of goal-oriented and model-based clinical pharmaeokinefic dosing of aminoglycosides on clinical outcome : a cost-effectiveness analy- sis显示文摘	VAN LENT EVENS NA MATHOT RA GEM WP	1999	Drug Monit1999，21，1：	1
19	Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring显示文摘	de Winter BC Mathot RA Sombogaard F	2011	Clin J Am Soe Nephrol2011，6，3：	1
20	Potential for improvement of docetaxel-based chemotherapy: a pharmacological review显示文摘	Engels FK Sparreboom A Mathot RA	2005	Br J Cancer2005，93，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示